Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Surg Case Rep ; 9(1): 66, 2023 Apr 27.
Article in English | MEDLINE | ID: mdl-37103609

ABSTRACT

BACKGROUND: Localized colorectal amyloidosis has a good prognosis, but cases involving bleeding or perforation may require surgery. However, there are few case reports discussing the differences in the surgical strategy between the segmental and pan-colon types. CASE PRESENTATION: A 69-year-old woman with a history of abdominal pain and melena was diagnosed with amyloidosis localized in the sigmoid colon by colonoscopy. Since preoperative imaging and intraoperative findings could not rule out malignancy, we performed laparoscopic sigmoid colectomy with lymph-node dissection. Histopathological examination and immunohistochemical staining revealed a diagnosis of AL amyloidosis (λ type). We diagnosed localized segmental gastrointestinal amyloidosis, because there was no amyloid protein in the margins, and the tumor was localized. There were no malignant findings. CONCLUSIONS: Unlike systemic amyloidosis, localized amyloidosis has a favorable prognosis. Localized colorectal amyloidosis can be classified into the segmental type, in which amyloid protein is deposited locally, and the pan-colon type, in which amyloid protein is deposited extensively in the colon. Amyloid protein causes ischemia due to vascular deposition, weakening of the intestinal wall due to muscle layer deposition, and decreased peristalsis due to nerve plexus deposition. No amyloid protein should remain outside the resection area. The pan-colon type is often reported to cause complications such as anastomotic leakage, and primary anastomosis should be avoided. On the other hand, if there is no contamination or tumor remnants in the margin, the segmental type may be considered for primary anastomosis.

2.
J Phys Chem Lett ; 14(2): 584-591, 2023 Jan 19.
Article in English | MEDLINE | ID: mdl-36633441

ABSTRACT

In layered materials, the layer-stacking sequence allows the tuning of ion transport and storage properties by modulating the host-ion interactions. However, unlike in the case of cations, the relationship between the stacking sequence and anion transport and storage properties is less clearly understood. Herein, we demonstrate that the stacking sequence governs the nitrate-storage properties of layered double hydroxides (LDHs); the 2H1 polytype enhances the nitrate-storage capacity to 400% of that of the 3R1 polytype. A quartz crystal microbalance with dissipation monitoring combined with multimodal ex situ experiments indicated that the high ion-storage capacity of the 2H1 polytype originates from the soft nature of LDHs lattices, which facilitates nitrate with minimal lattice changes. In contrast, the rigid lattice of the 3R1 sequence requires a notably large lattice expansion, which is detrimental to ion storage. Our findings can aid the rational design of anion-host interaction-derived functionalities.

3.
Nat Commun ; 13(1): 6448, 2022 Oct 28.
Article in English | MEDLINE | ID: mdl-36307449

ABSTRACT

Water-containing layered materials have found various applications such as water purification and energy storage. The highly structured water molecules around ions under the confinement between the layers determine the ion storage ability. Yet, the relationship between the configuration of interlayer ions and water structure in high ion storage layered materials is elusive. Herein, using layered double hydroxides, we demonstrate that the water structure is sensitive to the filling density of ions in the interlayer space and governs the ion storage. For ion storage of dilute nitrate ions, a 24% decrease in the filling density increases the nitrate storage capacity by 300%. Quartz crystal microbalance with dissipation monitoring studies, combined with multimodal ex situ experiments and theoretical calculations, reveal that the decreasing filling density effectively facilitates the 2D hydrogen-bond networking structure in water around interlayer nitrate ions along with minimal change in the layered structure, leading to the high storage capacity.

5.
Asian J Endosc Surg ; 14(3): 470-477, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33184994

ABSTRACT

INTRODUCTION: The International Guidelines for Groin Hernia Management recommends an anterior repair after a failed posterior repair, and laparoscopic repair after a failed anterior tissue repair or Lichtenstein repair. However, there are not enough studies to guide decision-making for patients with recurrent hernia patients after combined anterior-posterior repair. We investigate the safety and usefulness of transabdominal preperitoneal repair (TAPP) for recurrent hernia patients after failed anterior-posterior repair. METHODS: We conducted a retrospective analysis of 13 consecutive patients with recurrent groin hernia who underwent TAPP after prior anterior preperitoneal mesh repair (that created anterior and posterior scarring) between September 2013 and October 2018. The control group comprised 45 patients who underwent TAPP for recurrent hernia after anterior repair (43 nonmesh repairs and two Lichtenstein repairs). RESULTS: There were no intraoperative complications, and chronic pain was not reported by the patients with prior anterior preperitoneal mesh repair. The mean operative time was 113 ± 31.3 minutes, and the mean postoperative stay was 1.62 ± 0.87 days. The Wong-Baker FACES rating scale score for pain on postoperative day 1 was 1.91 ± 1.5; on postoperative day 7, the score was 1.0 ± 0.89. None of these findings was significantly different from the findings in patients who had a prior anterior repair. A single patient experienced a further recurrence and underwent repeat TAPP. CONCLUSIONS: The use of TAPP after failed combined anterior-posterior mesh repair may be feasible and safe for recurrent groin hernia. Further study is needed to determine long-term outcomes.


Subject(s)
Hernia, Femoral/surgery , Hernia, Inguinal , Herniorrhaphy , Laparoscopy , Aged , Aged, 80 and over , Female , Groin/surgery , Hernia, Inguinal/surgery , Herniorrhaphy/methods , Humans , Male , Middle Aged , Recurrence , Retrospective Studies , Surgical Mesh , Treatment Failure , Treatment Outcome
6.
Ann Surg Oncol ; 28(6): 3135-3144, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33128119

ABSTRACT

BACKGROUND: The clinical implications of pre- and postoperative KRAS-mutated circulating tumor DNA (ctDNA) present in patients with pancreatic ductal adenocarcinoma (PDAC) have remained an unresolved issue. This study sought to investigate the clinical significance of pre- and postoperative ctDNA analyses and their impact on the prognosis of PDAC patients. METHODS: Digital droplet polymerase chain reaction detected ctDNA in pre- and postoperative plasma samples prospectively obtained from patients with resectable and borderline-resectable PDAC. Its associations with recurrence-free survival (RFS) and overall survival (OS) were analyzed. The patients were sorted according to the presence of pre- and postoperative ctDNA, and its ability to stratify prognosis was evaluated. RESULTS: The study analyzed 97 patients. Both pre- and postoperative ctDNA were detected in 9 patients, and neither was detected in 55 patients. Whereas 15 patients harbored only preoperative ctDNA, 18 patients had only postoperative ctDNA. The multivariate analysis showed that the presence of preoperative ctDNA was associated with poorer OS (P = 0.008) and that postoperative ctDNA was not associated with either RFS or OS. Survival did not differ significantly between the patients with a positive shift in ctDNA status and those without detectable pre- or postoperative ctDNA. CONCLUSIONS: For the patients with PDAC, the presence of preoperative ctDNA was significantly associated poor OS, whereas postoperative ctDNA was not associated with poor survival. A positive change in ctDNA did not affect patients' survival.


Subject(s)
Adenocarcinoma , Carcinoma, Pancreatic Ductal , Circulating Tumor DNA , Pancreatic Neoplasms , Biomarkers, Tumor/genetics , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/surgery , Circulating Tumor DNA/genetics , Humans , Mutation , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/surgery , Prognosis
7.
J Diabetes Investig ; 11(6): 1434-1447, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32279428

ABSTRACT

AIMS/INTRODUCTION: Pancreatic islets are heterogenous. To clarify the relationship between islet heterogeneity and incretin action in the islets, we studied gene expression and metabolic profiles of non-large and enlarged islets of the Zucker fatty diabetes mellitus rat, an obese diabetes model, as well as incretin-induced insulin secretion (IIIS) in these islets. MATERIALS AND METHODS: Pancreatic islets of control (fa/+) and fatty (fa/fa) rats at 8 and 12 weeks-of-age were isolated. The islets of fa/fa rats at 12 weeks-of-age were separated into non-large islets (≤200 µm in diameter) and enlarged islets (>300 µm in diameter). Morphological analyses, insulin secretion experiments, transcriptome analysis, metabolome analysis and oxygen consumption analysis were carried out on these islets. RESULTS: The number of enlarged islets was increased with age in fatty rats, and IIIS was significantly reduced in the enlarged islets. Markers for ß-cell differentiation were markedly decreased in the enlarged islets, but those for cell proliferation were increased. Glycolysis was enhanced in the enlarged islets, whereas the tricarboxylic acid cycle was suppressed. The oxygen consumption rate under glucose stimulation was reduced in the enlarged islets. Production of glutamate, a key signal for IIIS, was decreased in the enlarged islets. CONCLUSIONS: The enlarged islets of Zucker fatty diabetes mellitus rats, which are defective for IIIS, show tumor cell-like metabolic features, including a dedifferentiated state, accelerated aerobic glycolysis and impaired mitochondrial function. The age-dependent increase in such islets could contribute to the pathophysiology of obese diabetes.


Subject(s)
Gene Expression Regulation/drug effects , Incretins/toxicity , Insulin Secretion/drug effects , Islets of Langerhans/pathology , Metabolome/drug effects , Obesity/physiopathology , Pancreatic Neoplasms/pathology , Animals , Gene Expression Profiling , Islets of Langerhans/drug effects , Male , Pancreatic Neoplasms/chemically induced , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism , Rats , Rats, Zucker
8.
PLoS One ; 15(2): e0215113, 2020.
Article in English | MEDLINE | ID: mdl-32107484

ABSTRACT

Reinforcement of the hydroperoxide-eliminating activity in the small and large intestines should prevent associated diseases. We previously isolated a lactic acid bacterium, Pediococcus pentosaceus Be1 that facilitates a 2-electron reduction of hydrogen peroxide to water. In this study, we successfully isolated an alternative lactic acid bacterium, Lactobacillus plantarum P1-2, that can efficiently reduce environmental alkyl hydroperoxides and fatty acid hydroperoxides to their corresponding hydroxyl derivatives through a 2-electron reduction. Each strain exhibited a wide concentration range with regard to the environmental reducing activity for each hydroperoxide. Given this, the two lactic acid bacteria were orally administered to an oxygen-sensitive short-lived nematode mutant, and this resulted in a significant expansion of its lifespan. This observation suggests that P. pentosaceus Be1 and L. plantarum P1-2 inhibit internal oxidative stress. To determine the specific organs involved in this response, we performed a similar experiment in rats, involving induced lipid peroxidation by iron-overloading. We observed that only L. plantarum P1-2 inhibited colonic mucosa lipid peroxidation in rats with induced oxidative stress.


Subject(s)
Intestinal Mucosa/microbiology , Lactobacillus plantarum/metabolism , Lipid Peroxides/metabolism , Oxidative Stress , Animals , Caenorhabditis elegans , Intestinal Mucosa/metabolism , Lactobacillus plantarum/pathogenicity , Male , Oxidation-Reduction , Rats , Rats, Wistar
9.
Water Res ; 118: 177-186, 2017 07 01.
Article in English | MEDLINE | ID: mdl-28431350

ABSTRACT

We evaluated 51 poly-aluminum chloride (PACl) coagulants to determine the coagulant characteristics that were responsible for effective arsenate removal from contaminated river water by means of experiments involving coagulation, settling, and microfiltration. Some of the high-basicity PACls exhibited high arsenate removal percentages, particularly under alkaline conditions, and we investigated various relevant properties and characteristics of these high-basicity PACls. Effective arsenate removal was correlated with the content of polymeric and colloidal aluminum species (Alb and Alc) in the PACls but was not well correlated with colloid charge or zeta potential. Multiple regression analysis revealed that a portion of Alb and Alc, which reacted with the ferron reagent during the period from 30 min to 3 h, that is, the (Al30min-3h) fraction, had the highest arsenate sorption capacity, followed by a colloidal aluminum fraction (Al>3h, which reacted with ferron at a time of >3 h). The Al30min-3h fraction was stable, and its arsenate sorption capacity did not decrease markedly with increasing pH. The Al30min-3h fraction did not correspond to the Keggin-type e-Al13 polycation or the δ-Al30 polycation; it is likely to be an aluminum polymer that is unobservable by 27Al NMR spectroscopy. Our results suggest that PACls with a high proportion of the Al30min-3h fraction should be used for enhanced arsenate removal by coagulation. A high content of the e-Al13 polycation or the δ-Al30 polycation was not indispensable for effective arsenate removal.


Subject(s)
Aluminum Compounds/chemistry , Chlorides/chemistry , Water Purification , Aluminum , Aluminum Chloride , Aluminum Hydroxide , Arsenates , Hydrogen-Ion Concentration
10.
Int Cancer Conf J ; 5(1): 40-44, 2016 Jan.
Article in English | MEDLINE | ID: mdl-31149421

ABSTRACT

Pyopneumothorax is a rare but troubling complication of bevacizumab. We herein report a case of pyopneumothorax in a patient with metastatic breast cancer during bevacizumab treatment. A 60-year-old female who was diagnosed with metastatic breast cancer (ER+ , PgR+ , HER2-, Ki67 <14 %, metastasized to lung, pleural, brain, subcutaneous tissue, and bone) was started on bevacizumab plus paclitaxel chemotherapy. Although the disease was well-controlled, pyopneumothorax was noted after 3 months of treatment and the chemotherapy was therefore stopped immediately. The pyopneumothorax was so intractable that no conservative treatment could successfully manage it. The patient underwent a radical operation using the technique of latissimus dorsi muscle transfer. The operation improved her general condition and lead to hormonal therapy. Our case indicates the successful management of a severe side effect of bevacizumab for a breast cancer patient.

11.
J Diabetes Res ; 2015: 261418, 2015.
Article in English | MEDLINE | ID: mdl-25961052

ABSTRACT

We recently established a novel animal model of obese type 2 diabetes (T2D), the Zucker fatty diabetes mellitus (ZFDM) rat strain harboring the fatty mutation (fa) in the leptin receptor gene. Here we performed a phenotypic characterization of the strain, focusing mainly on the prediabetic state. At 6-8 weeks of age, fa/fa male rats exhibited mild glucose intolerance and severe insulin resistance. Although basal insulin secretion was remarkably high in the isolated pancreatic islets, the responses to both glucose stimulation and the incretin GLP-1 were retained. At 10-12 weeks of age, fa/fa male rats exhibited marked glucose intolerance as well as severe insulin resistance similar to that at the earlier age. In the pancreatic islets, the insulin secretory response to glucose stimulation was maintained but the response to the incretin was diminished. In nondiabetic Zucker fatty (ZF) rats, the insulin secretory responses to both glucose stimulation and the incretin in the pancreatic islets were similar to those of ZFDM rats. As islet architecture was destroyed with age in ZFDM rats, a combination of severe insulin resistance, diminished insulin secretory response to incretin, and intrinsic fragility of the islets may cause the development of T2D in this strain.


Subject(s)
Diabetes Mellitus, Type 2/physiopathology , Disease Models, Animal , Glucose Intolerance/physiopathology , Insulin Resistance/physiology , Obesity/physiopathology , Prediabetic State/physiopathology , Animals , Diabetes Mellitus, Type 2/genetics , Glucose Intolerance/genetics , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/metabolism , Male , Obesity/genetics , Prediabetic State/genetics , Rats , Rats, Zucker , Receptors, Leptin/genetics
12.
World J Gastroenterol ; 21(6): 1982-8, 2015 Feb 14.
Article in English | MEDLINE | ID: mdl-25684967

ABSTRACT

A 72-year-old woman with a sigmoid colon cancer and a synchronous colorectal liver metastasis (CRLM), which involved the right hepatic vein (RHV) and the inferior vena cava (IVC), was referred to our hospital. The metastatic lesion was diagnosed as initially unresectable because of its invasion into the confluence of the RHV and IVC. After she had undergone laparoscopic sigmoidectomy for the original tumor, she consequently had 3 courses of modified 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus cetuximab. Computed tomography revealed a partial response, and the confluence of the RHV and IVC got free from cancer invasion. After 3 additional courses of mFOLFOX6 plus cetuximab, preoperative percutaneous transhepatic portal vein embolization (PTPE) was performed to secure the future remnant liver volume. Finally, a right hemihepatectomy was performed. The postoperative course was uneventful. The patient was discharged from the hospital on postoperative day 13. She had neither local recurrence nor distant metastasis 18 mo after the last surgical intervention. This multidisciplinary strategy, consisting of conversion chemotherapy using FOLFOX plus cetuximab and PTPE, could contribute in facilitating curative hepatic resection for initially unresectable CRLM.


Subject(s)
Adenocarcinoma/secondary , Adenocarcinoma/therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colorectal Neoplasms/pathology , Hepatectomy , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Neoadjuvant Therapy , Adenocarcinoma/drug therapy , Adenocarcinoma/surgery , Aged , Antibodies, Monoclonal, Humanized/administration & dosage , Biopsy , Cetuximab , Chemotherapy, Adjuvant , Cholecystectomy , Embolization, Therapeutic , Female , Fluorouracil/administration & dosage , Humans , Leucovorin/administration & dosage , Liver Neoplasms/drug therapy , Liver Neoplasms/surgery , Neoplasm Invasiveness , Organoplatinum Compounds/administration & dosage , Oxaliplatin , Tomography, X-Ray Computed , Treatment Outcome
13.
J Biomed Biotechnol ; 2010: 569053, 2010.
Article in English | MEDLINE | ID: mdl-20625494

ABSTRACT

Gangliosides GM1 is a good marker of membrane microdomains (lipid rafts) with important function in cellular activation processes. In this study we found that GM1 expression on CD4+ T cells and memory T cells (CD45RO/CD4) were dramatic increased after stimulation with phytohaemagglutinin in vitro. Next, we examined the GM1 expression on peripheral blood CD4+ T cells and CD8+ T cells from 44 patients with SLE and 28 healthy controls by flow cytometry. GM1 expression was further analyzed with serum soluble CD30 (sCD30), IL-10, TNF-alpha and clinical parameters. The mean fluorescence intensity of GM1 on CD4+ T cells from patients with SLE was significantly higher than those from healthy controls, but not on CD8+ T cells. Increased expression of GM1 was more marked on CD4+/CD45RO+ memory T cells from active SLE patients. Patients with SLE showed significantly elevated serum sCD30 and IL-10, but not TNF-alpha levels. In addition, we found that enhanced GM1 expression on CD4+ T cells from patients with SLE positively correlated with high serum levels of sCD30 and IgG as well as disease activity (SLEDAI scores). Our data suggested the potential role of aberrant lipid raft/GM1 on CD4+ T cells and sCD30 in the pathogenesis of SLE.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , G(M1) Ganglioside/immunology , Ki-1 Antigen/immunology , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/immunology , CD4-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Humans , Immunoglobulin G/immunology , Immunologic Memory/drug effects , Interleukin-10/blood , Ki-1 Antigen/blood , Kinetics , Lymphocyte Activation/drug effects , Lymphocyte Activation/immunology , Membrane Microdomains/immunology , Phytohemagglutinins/pharmacology , Solubility/drug effects , Time Factors , Tumor Necrosis Factor-alpha/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...